

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | otic vesicle formation (GO:0030916) | 7.99152696 |
| 2 | mesenchymal-epithelial cell signaling (GO:0060638) | 7.85640682 |
| 3 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 6.95925499 |
| 4 | negative regulation of stress fiber assembly (GO:0051497) | 6.67836335 |
| 5 | lateral sprouting from an epithelium (GO:0060601) | 6.62962400 |
| 6 | epithelial cell differentiation involved in kidney development (GO:0035850) | 6.61961581 |
| 7 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 6.60660790 |
| 8 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 6.45213905 |
| 9 | negative regulation of Rho protein signal transduction (GO:0035024) | 6.42897936 |
| 10 | radial glial cell differentiation (GO:0060019) | 6.22683300 |
| 11 | muscle cell fate commitment (GO:0042693) | 6.07061754 |
| 12 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 5.63390486 |
| 13 | lung epithelium development (GO:0060428) | 5.57404584 |
| 14 | endothelium development (GO:0003158) | 5.52659252 |
| 15 | surfactant homeostasis (GO:0043129) | 5.45077092 |
| 16 | negative regulation of actin filament bundle assembly (GO:0032232) | 5.36162267 |
| 17 | striated muscle hypertrophy (GO:0014897) | 5.26251485 |
| 18 | camera-type eye morphogenesis (GO:0048593) | 5.25567592 |
| 19 | embryonic camera-type eye development (GO:0031076) | 5.12851299 |
| 20 | regulation of axon guidance (GO:1902667) | 5.10671198 |
| 21 | organ growth (GO:0035265) | 5.07412650 |
| 22 | bicarbonate transport (GO:0015701) | 4.88732355 |
| 23 | actin-myosin filament sliding (GO:0033275) | 4.85837376 |
| 24 | muscle filament sliding (GO:0030049) | 4.85837376 |
| 25 | metanephric epithelium development (GO:0072207) | 4.84201168 |
| 26 | limb bud formation (GO:0060174) | 4.79958589 |
| 27 | induction of positive chemotaxis (GO:0050930) | 4.78688096 |
| 28 | muscle hypertrophy (GO:0014896) | 4.78466260 |
| 29 | protein localization to cell surface (GO:0034394) | 4.78182660 |
| 30 | myelination in peripheral nervous system (GO:0022011) | 4.77899825 |
| 31 | peripheral nervous system axon ensheathment (GO:0032292) | 4.77899825 |
| 32 | negative regulation of axon guidance (GO:1902668) | 4.70516770 |
| 33 | striated muscle adaptation (GO:0014888) | 4.70364593 |
| 34 | neuronal ion channel clustering (GO:0045161) | 4.54980218 |
| 35 | chemical homeostasis within a tissue (GO:0048875) | 4.41982027 |
| 36 | genitalia morphogenesis (GO:0035112) | 4.39312792 |
| 37 | negative regulation of metanephros development (GO:0072217) | 4.33693636 |
| 38 | facial nerve structural organization (GO:0021612) | 4.30292151 |
| 39 | regulation of mitochondrial depolarization (GO:0051900) | 4.27915126 |
| 40 | positive regulation of cell junction assembly (GO:1901890) | 4.23944307 |
| 41 | positive regulation of focal adhesion assembly (GO:0051894) | 4.23944307 |
| 42 | cell differentiation involved in kidney development (GO:0061005) | 4.20044860 |
| 43 | kidney mesenchyme development (GO:0072074) | 4.19944722 |
| 44 | mesonephros development (GO:0001823) | 4.18890943 |
| 45 | actin-mediated cell contraction (GO:0070252) | 4.15356829 |
| 46 | excretion (GO:0007588) | 4.12686619 |
| 47 | myofibril assembly (GO:0030239) | 4.12579462 |
| 48 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.05135177 |
| 49 | regulation of axon extension involved in axon guidance (GO:0048841) | 4.04827765 |
| 50 | regulation of skeletal muscle contraction (GO:0014819) | 4.03018318 |
| 51 | positive regulation of adherens junction organization (GO:1903393) | 4.02824193 |
| 52 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.94970025 |
| 53 | regulation of relaxation of muscle (GO:1901077) | 3.94750310 |
| 54 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.94588027 |
| 55 | positive regulation of protein kinase C signaling (GO:0090037) | 3.89379417 |
| 56 | short-term memory (GO:0007614) | 3.87497764 |
| 57 | lung secretory cell differentiation (GO:0061140) | 3.86307634 |
| 58 | postsynaptic membrane organization (GO:0001941) | 3.82722543 |
| 59 | cellular response to reactive nitrogen species (GO:1902170) | 3.82303780 |
| 60 | metanephric mesenchyme development (GO:0072075) | 3.76971830 |
| 61 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.75588108 |
| 62 | response to mercury ion (GO:0046689) | 3.74861643 |
| 63 | muscle adaptation (GO:0043500) | 3.74079806 |
| 64 | endothelial cell chemotaxis (GO:0035767) | 3.71508950 |
| 65 | kidney morphogenesis (GO:0060993) | 3.71438724 |
| 66 | nephron epithelium development (GO:0072009) | 3.69708291 |
| 67 | regulation of glomerular filtration (GO:0003093) | 3.66891871 |
| 68 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.65633910 |
| 69 | metanephric nephron tubule development (GO:0072234) | 3.65154304 |
| 70 | metanephric tubule development (GO:0072170) | 3.65154304 |
| 71 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 3.64843233 |
| 72 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.64264785 |
| 73 | regulation of ruffle assembly (GO:1900027) | 3.60818613 |
| 74 | branch elongation of an epithelium (GO:0060602) | 3.59384519 |
| 75 | keratinocyte proliferation (GO:0043616) | 3.58371684 |
| 76 | metanephric nephron epithelium development (GO:0072243) | 3.54662799 |
| 77 | lymphangiogenesis (GO:0001946) | 3.54301361 |
| 78 | actin filament-based movement (GO:0030048) | 3.53199411 |
| 79 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.52743432 |
| 80 | embryonic digestive tract morphogenesis (GO:0048557) | 3.52061860 |
| 81 | angiotensin maturation (GO:0002003) | 3.51344057 |
| 82 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.50792421 |
| 83 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.49495424 |
| 84 | auditory receptor cell stereocilium organization (GO:0060088) | 3.48378701 |
| 85 | skeletal muscle contraction (GO:0003009) | 3.47131979 |
| 86 | white fat cell differentiation (GO:0050872) | 3.46660743 |
| 87 | cranial nerve structural organization (GO:0021604) | 3.43984124 |
| 88 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.43706448 |
| 89 | presynaptic membrane assembly (GO:0097105) | 3.42116684 |
| 90 | lymph vessel development (GO:0001945) | 3.40905681 |
| 91 | myoblast fusion (GO:0007520) | 3.36062079 |
| 92 | cellular response to nitric oxide (GO:0071732) | 3.35179966 |
| 93 | renal system process involved in regulation of blood volume (GO:0001977) | 3.34476157 |
| 94 | renal filtration (GO:0097205) | 3.30258598 |
| 95 | thyroid gland development (GO:0030878) | 3.28161630 |
| 96 | positive regulation of metanephros development (GO:0072216) | 3.27995967 |
| 97 | coronary vasculature morphogenesis (GO:0060977) | 3.26576068 |
| 98 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.25894491 |
| 99 | phosphate ion transmembrane transport (GO:0035435) | 3.25655138 |
| 100 | organ induction (GO:0001759) | 3.24905596 |
| 101 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.21428567 |
| 102 | organ formation (GO:0048645) | 3.17602890 |
| 103 | pattern specification involved in kidney development (GO:0061004) | 3.16945640 |
| 104 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.16203902 |
| 105 | regulation of male gonad development (GO:2000018) | 3.16083879 |
| 106 | smooth muscle cell differentiation (GO:0051145) | 3.15217114 |
| 107 | phosphate ion transport (GO:0006817) | 3.14414247 |
| 108 | cell differentiation involved in metanephros development (GO:0072202) | 3.13070455 |
| 109 | positive regulation of p38MAPK cascade (GO:1900745) | 3.12037054 |
| 110 | sarcomere organization (GO:0045214) | 3.09569288 |
| 111 | cardiac myofibril assembly (GO:0055003) | 3.05958821 |
| 112 | neuron remodeling (GO:0016322) | 3.03613461 |
| 113 | morphogenesis of an epithelial fold (GO:0060571) | 3.02941699 |
| 114 | mesodermal cell differentiation (GO:0048333) | 3.02573624 |
| 115 | positive regulation of steroid hormone secretion (GO:2000833) | 3.00590147 |
| 116 | response to inactivity (GO:0014854) | 2.99702017 |
| 117 | venous blood vessel morphogenesis (GO:0048845) | 2.99488226 |
| 118 | positive regulation of digestive system process (GO:0060456) | 2.97913191 |
| 119 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.97893007 |
| 120 | mesenchymal to epithelial transition (GO:0060231) | 2.97806142 |
| 121 | regulation of actin filament-based movement (GO:1903115) | 2.97356417 |
| 122 | ERK1 and ERK2 cascade (GO:0070371) | 2.96939936 |
| 123 | smooth muscle tissue development (GO:0048745) | 2.96531292 |
| 124 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.95532804 |
| 125 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.95532804 |
| 126 | mesenchymal cell differentiation (GO:0048762) | 2.95413928 |
| 127 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.94631516 |
| 128 | glomerular filtration (GO:0003094) | 2.93454929 |
| 129 | positive regulation of male gonad development (GO:2000020) | 2.93413555 |
| 130 | regulation of digestive system process (GO:0044058) | 2.89630947 |
| 131 | regulation of Rho protein signal transduction (GO:0035023) | 2.89583491 |
| 132 | regulation of keratinocyte proliferation (GO:0010837) | 2.88804539 |
| 133 | actomyosin structure organization (GO:0031032) | 2.87471085 |
| 134 | regulation of glomerulus development (GO:0090192) | 2.87366329 |
| 135 | diaphragm development (GO:0060539) | 2.85631317 |
| 136 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.85187843 |
| 137 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.85174237 |
| 138 | epithelial tube formation (GO:0072175) | 2.85053057 |
| 139 | response to nitric oxide (GO:0071731) | 2.83356824 |
| 140 | striated muscle contraction (GO:0006941) | 2.83328566 |
| 141 | response to epinephrine (GO:0071871) | 2.81835178 |
| 142 | presynaptic membrane organization (GO:0097090) | 2.81523662 |
| 143 | axis elongation (GO:0003401) | 2.81237543 |
| 144 | positive regulation of mesonephros development (GO:0061213) | 2.79962813 |
| 145 | cell adhesion mediated by integrin (GO:0033627) | 2.79898208 |
| 146 | cellular hyperosmotic response (GO:0071474) | 2.78248730 |
| 147 | kidney epithelium development (GO:0072073) | 2.78091443 |
| 148 | regulation of mesonephros development (GO:0061217) | 2.77722882 |
| 149 | negative regulation of kidney development (GO:0090185) | 2.77377842 |
| 150 | wound healing, spreading of epidermal cells (GO:0035313) | 2.75575603 |
| 151 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.74724108 |
| 152 | lung vasculature development (GO:0060426) | 2.72761044 |
| 153 | regulation of platelet aggregation (GO:0090330) | 2.71253442 |
| 154 | positive regulation of vascular permeability (GO:0043117) | 2.70323225 |
| 155 | polyol transport (GO:0015791) | 2.68272203 |
| 156 | nucleus localization (GO:0051647) | 2.68248644 |
| 157 | cell migration involved in heart development (GO:0060973) | 2.65949800 |
| 158 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.65055905 |
| 159 | activation of Rac GTPase activity (GO:0032863) | 2.64494676 |
| 160 | establishment of nucleus localization (GO:0040023) | 2.63581927 |
| 161 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.63503407 |
| 162 | dopaminergic neuron differentiation (GO:0071542) | 2.62799277 |
| 163 | omega-hydroxylase P450 pathway (GO:0097267) | 2.62409778 |
| 164 | sprouting angiogenesis (GO:0002040) | 2.62292882 |
| 165 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.61188947 |
| 166 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.60894565 |
| 167 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.60661610 |
| 168 | nephron tubule development (GO:0072080) | 2.59508214 |
| 169 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.58626282 |
| 170 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.55414466 |
| 171 | negative regulation of chemotaxis (GO:0050922) | 2.53138920 |
| 172 | negative regulation of platelet activation (GO:0010544) | 2.52505579 |
| 173 | regulation of pigment cell differentiation (GO:0050932) | 2.49680325 |
| 174 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.48846407 |
| 175 | ureteric bud development (GO:0001657) | 2.48592965 |
| 176 | T-helper 1 type immune response (GO:0042088) | 2.47034686 |
| 177 | regulation of alkaline phosphatase activity (GO:0010692) | 2.45838707 |
| 178 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.45463276 |
| 179 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.44409473 |
| 180 | drug transmembrane transport (GO:0006855) | 2.44076022 |
| 181 | phospholipid scrambling (GO:0017121) | 2.43090913 |
| 182 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.41183728 |
| 183 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.40957114 |
| 184 | reflex (GO:0060004) | 2.40893330 |
| 185 | glomerular visceral epithelial cell development (GO:0072015) | 18.4101135 |
| 186 | glomerular epithelial cell development (GO:0072310) | 16.3930117 |
| 187 | * glomerular basement membrane development (GO:0032836) | 11.9819377 |
| 188 | glomerulus development (GO:0032835) | 10.8336179 |
| 189 | skeletal muscle adaptation (GO:0043501) | 10.0897247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.89554570 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.25940777 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71388151 |
| 4 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.70882927 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.67477585 |
| 6 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.58095911 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.56813155 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.42067956 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38730793 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38730793 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.35195032 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29254450 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29035940 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.28709872 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.28437488 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.24585445 |
| 17 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.23385759 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18604086 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16433506 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.02156631 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.98720529 |
| 22 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.97198794 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.96713012 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.95256152 |
| 25 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.90139764 |
| 26 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.87872069 |
| 27 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.87802325 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.87280746 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.87258712 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85699318 |
| 31 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.85052736 |
| 32 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.75690992 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.73346673 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.73071356 |
| 35 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.72003883 |
| 36 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.72003883 |
| 37 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.71195304 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.70455910 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.69894357 |
| 40 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.67731541 |
| 41 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.62661124 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61858363 |
| 43 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.60875421 |
| 44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.60043214 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58208180 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56667173 |
| 47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54427042 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53904499 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.52213901 |
| 50 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51909033 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48534696 |
| 52 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.45937396 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.43542970 |
| 54 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.43072228 |
| 55 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42755164 |
| 56 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41740492 |
| 57 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.40982332 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40107416 |
| 59 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.39023305 |
| 60 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37612548 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36102644 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35786920 |
| 63 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.34486252 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.33923211 |
| 65 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.33080882 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32733533 |
| 67 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32579676 |
| 68 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29210989 |
| 69 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28890523 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27479722 |
| 71 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26577202 |
| 72 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26035498 |
| 73 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.25999697 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25063640 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24829028 |
| 76 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.24085282 |
| 77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23307675 |
| 78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23170459 |
| 79 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22479707 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22077520 |
| 81 | CJUN_26792858_Chip-Seq_BT549_Human | 1.21732211 |
| 82 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21721900 |
| 83 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20748016 |
| 84 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19790693 |
| 85 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.19544564 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19334744 |
| 87 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19042888 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.19010331 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18688793 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18688793 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17160839 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16978454 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16075200 |
| 94 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15209811 |
| 95 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14316175 |
| 96 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13746190 |
| 97 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13693375 |
| 98 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12694768 |
| 99 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12337604 |
| 100 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12018135 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11548224 |
| 102 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10078001 |
| 103 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09267575 |
| 104 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07811347 |
| 105 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06851098 |
| 106 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06841690 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.05809316 |
| 108 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05336181 |
| 109 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05001328 |
| 110 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04770279 |
| 111 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04658681 |
| 112 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03912455 |
| 113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03717241 |
| 114 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02929008 |
| 115 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02843824 |
| 116 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02707515 |
| 117 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02597869 |
| 118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02596980 |
| 119 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.02352935 |
| 120 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01773139 |
| 121 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01479783 |
| 122 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00641111 |
| 123 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00430656 |
| 124 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99933451 |
| 125 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.99084551 |
| 126 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98206772 |
| 127 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97960189 |
| 128 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97816319 |
| 129 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97292244 |
| 130 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96182695 |
| 131 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95009482 |
| 132 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.94963761 |
| 133 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94685330 |
| 134 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94452636 |
| 135 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.93969330 |
| 136 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92969117 |
| 137 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.92957255 |
| 138 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.92648589 |
| 139 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92610530 |
| 140 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92474192 |
| 141 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92367412 |
| 142 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91558602 |
| 143 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.91346323 |
| 144 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90600482 |
| 145 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90297485 |
| 146 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.90209031 |
| 147 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89759742 |
| 148 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89026729 |
| 149 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88916243 |
| 150 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88861937 |
| 151 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88492267 |
| 152 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87933208 |
| 153 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86937276 |
| 154 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85441183 |
| 155 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84224421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005257_abnormal_intraocular_pressure | 5.76915166 |
| 2 | MP0005623_abnormal_meninges_morphology | 3.92889261 |
| 3 | MP0005409_darkened_coat_color | 3.83828930 |
| 4 | MP0003136_yellow_coat_color | 3.59881473 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.57083243 |
| 6 | MP0001879_abnormal_lymphatic_vessel | 3.47071060 |
| 7 | MP0010368_abnormal_lymphatic_system | 3.37049963 |
| 8 | MP0003646_muscle_fatigue | 3.23983002 |
| 9 | MP0005248_abnormal_Harderian_gland | 3.08922994 |
| 10 | MP0003724_increased_susceptibility_to | 2.91011417 |
| 11 | MP0002132_abnormal_respiratory_system | 2.71587902 |
| 12 | MP0001188_hyperpigmentation | 2.57949102 |
| 13 | MP0003880_abnormal_central_pattern | 2.52305639 |
| 14 | * MP0002136_abnormal_kidney_physiology | 2.43279502 |
| 15 | MP0004043_abnormal_pH_regulation | 2.40817383 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.37433931 |
| 17 | MP0004381_abnormal_hair_follicle | 2.32428065 |
| 18 | MP0000749_muscle_degeneration | 2.24226665 |
| 19 | MP0000751_myopathy | 2.12694184 |
| 20 | MP0002332_abnormal_exercise_endurance | 2.09735670 |
| 21 | * MP0009643_abnormal_urine_homeostasis | 2.09193849 |
| 22 | MP0003941_abnormal_skin_development | 2.03588287 |
| 23 | MP0003942_abnormal_urinary_system | 2.02910174 |
| 24 | * MP0004272_abnormal_basement_membrane | 2.00210438 |
| 25 | * MP0000230_abnormal_systemic_arterial | 1.98673386 |
| 26 | * MP0005332_abnormal_amino_acid | 1.93260689 |
| 27 | MP0009384_cardiac_valve_regurgitation | 1.87483960 |
| 28 | MP0001958_emphysema | 1.80671192 |
| 29 | MP0003879_abnormal_hair_cell | 1.79258594 |
| 30 | MP0001765_abnormal_ion_homeostasis | 1.77790271 |
| 31 | MP0000013_abnormal_adipose_tissue | 1.75606956 |
| 32 | MP0003938_abnormal_ear_development | 1.72055321 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 1.71582676 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.70636462 |
| 35 | * MP0002135_abnormal_kidney_morphology | 1.69420635 |
| 36 | MP0002009_preneoplasia | 1.67836521 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.67690922 |
| 38 | MP0004087_abnormal_muscle_fiber | 1.67623227 |
| 39 | MP0000747_muscle_weakness | 1.62266854 |
| 40 | MP0000534_abnormal_ureter_morphology | 1.59857207 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.58646144 |
| 42 | MP0000566_synostosis | 1.57330371 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.51066909 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.50732930 |
| 45 | MP0003045_fibrosis | 1.50663928 |
| 46 | MP0005330_cardiomyopathy | 1.48749584 |
| 47 | MP0003878_abnormal_ear_physiology | 1.48130567 |
| 48 | MP0005377_hearing/vestibular/ear_phenot | 1.48130567 |
| 49 | MP0004084_abnormal_cardiac_muscle | 1.46390302 |
| 50 | MP0005369_muscle_phenotype | 1.45348938 |
| 51 | MP0004885_abnormal_endolymph | 1.45251469 |
| 52 | MP0005595_abnormal_vascular_smooth | 1.45069724 |
| 53 | MP0005165_increased_susceptibility_to | 1.41485838 |
| 54 | MP0008995_early_reproductive_senescence | 1.39924865 |
| 55 | MP0002108_abnormal_muscle_morphology | 1.38114733 |
| 56 | MP0002269_muscular_atrophy | 1.37174558 |
| 57 | MP0002177_abnormal_outer_ear | 1.35239326 |
| 58 | MP0000049_abnormal_middle_ear | 1.34851069 |
| 59 | MP0000759_abnormal_skeletal_muscle | 1.33219558 |
| 60 | MP0006292_abnormal_olfactory_placode | 1.31960970 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.30689122 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.29353799 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.26959181 |
| 64 | MP0002295_abnormal_pulmonary_circulatio | 1.26092908 |
| 65 | MP0001486_abnormal_startle_reflex | 1.25913431 |
| 66 | MP0003315_abnormal_perineum_morphology | 1.24693203 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.23827303 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.23596444 |
| 69 | * MP0001963_abnormal_hearing_physiology | 1.22372445 |
| 70 | MP0005620_abnormal_muscle_contractility | 1.20817785 |
| 71 | MP0003828_pulmonary_edema | 1.20108602 |
| 72 | MP0004742_abnormal_vestibular_system | 1.17205600 |
| 73 | MP0005197_abnormal_uvea_morphology | 1.15565458 |
| 74 | MP0003937_abnormal_limbs/digits/tail_de | 1.13788318 |
| 75 | MP0009250_abnormal_appendicular_skeleto | 1.13703113 |
| 76 | * MP0000026_abnormal_inner_ear | 1.12158438 |
| 77 | MP0003303_peritoneal_inflammation | 1.10109908 |
| 78 | MP0002249_abnormal_larynx_morphology | 1.10035676 |
| 79 | MP0000920_abnormal_myelination | 1.10023868 |
| 80 | MP0004036_abnormal_muscle_relaxation | 1.09758100 |
| 81 | * MP0001756_abnormal_urination | 1.09157880 |
| 82 | MP0005503_abnormal_tendon_morphology | 1.08655606 |
| 83 | MP0004019_abnormal_vitamin_homeostasis | 1.07750380 |
| 84 | MP0000733_abnormal_muscle_development | 1.07300304 |
| 85 | MP0001502_abnormal_circadian_rhythm | 1.07266487 |
| 86 | MP0002933_joint_inflammation | 1.06477863 |
| 87 | MP0000579_abnormal_nail_morphology | 1.05350425 |
| 88 | MP0004233_abnormal_muscle_weight | 1.04268762 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 1.03317265 |
| 90 | MP0002102_abnormal_ear_morphology | 1.02053156 |
| 91 | MP0003195_calcinosis | 1.01994537 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 1.01535451 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.99783475 |
| 94 | MP0004130_abnormal_muscle_cell | 0.99199912 |
| 95 | MP0008004_abnormal_stomach_pH | 0.98431365 |
| 96 | MP0005451_abnormal_body_composition | 0.96858655 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.96674225 |
| 98 | MP0002972_abnormal_cardiac_muscle | 0.95702555 |
| 99 | MP0005551_abnormal_eye_electrophysiolog | 0.94233590 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.94019257 |
| 101 | MP0003091_abnormal_cell_migration | 0.93352962 |
| 102 | MP0001501_abnormal_sleep_pattern | 0.91235411 |
| 103 | MP0004215_abnormal_myocardial_fiber | 0.90084956 |
| 104 | MP0000163_abnormal_cartilage_morphology | 0.87348439 |
| 105 | MP0001346_abnormal_lacrimal_gland | 0.86651764 |
| 106 | MP0002752_abnormal_somatic_nervous | 0.86492509 |
| 107 | MP0000778_abnormal_nervous_system | 0.86402864 |
| 108 | MP0004085_abnormal_heartbeat | 0.85178414 |
| 109 | MP0002098_abnormal_vibrissa_morphology | 0.85028747 |
| 110 | MP0002168_other_aberrant_phenotype | 0.84951462 |
| 111 | MP0000003_abnormal_adipose_tissue | 0.83926109 |
| 112 | MP0000767_abnormal_smooth_muscle | 0.83075754 |
| 113 | MP0008260_abnormal_autophagy | 0.82625623 |
| 114 | MP0010030_abnormal_orbit_morphology | 0.82287240 |
| 115 | MP0002133_abnormal_respiratory_system | 0.82103722 |
| 116 | MP0005388_respiratory_system_phenotype | 0.82103722 |
| 117 | MP0010630_abnormal_cardiac_muscle | 0.81158547 |
| 118 | MP0001324_abnormal_eye_pigmentation | 0.80891571 |
| 119 | MP0000470_abnormal_stomach_morphology | 0.80072629 |
| 120 | MP0006138_congestive_heart_failure | 0.79629460 |
| 121 | MP0003137_abnormal_impulse_conducting | 0.78898923 |
| 122 | MP0002998_abnormal_bone_remodeling | 0.76757789 |
| 123 | MP0005195_abnormal_posterior_eye | 0.76688070 |
| 124 | * MP0005193_abnormal_anterior_eye | 0.73493761 |
| 125 | MP0001286_abnormal_eye_development | 0.73390853 |
| 126 | MP0004484_altered_response_of | 0.73152231 |
| 127 | MP0000762_abnormal_tongue_morphology | 0.72686038 |
| 128 | MP0000372_irregular_coat_pigmentation | 0.72420030 |
| 129 | MP0001664_abnormal_digestion | 0.72016328 |
| 130 | MP0003385_abnormal_body_wall | 0.71453884 |
| 131 | MP0001784_abnormal_fluid_regulation | 0.70742104 |
| 132 | MP0000613_abnormal_salivary_gland | 0.70555784 |
| 133 | MP0005266_abnormal_metabolism | 0.69888075 |
| 134 | MP0005381_digestive/alimentary_phenotyp | 0.69572880 |
| 135 | MP0002233_abnormal_nose_morphology | 0.69449871 |
| 136 | MP0001340_abnormal_eyelid_morphology | 0.67360895 |
| 137 | MP0000569_abnormal_digit_pigmentation | 0.65578286 |
| 138 | MP0001270_distended_abdomen | 0.65169660 |
| 139 | MP0002067_abnormal_sensory_capabilities | 0.63684598 |
| 140 | MP0002127_abnormal_cardiovascular_syste | 0.63595423 |
| 141 | MP0001919_abnormal_reproductive_system | 0.63512242 |
| 142 | MP0000462_abnormal_digestive_system | 0.63030520 |
| 143 | MP0000383_abnormal_hair_follicle | 0.62094807 |
| 144 | MP0009780_abnormal_chondrocyte_physiolo | 0.61474353 |
| 145 | MP0001299_abnormal_eye_distance/ | 0.60892787 |
| 146 | MP0003300_gastrointestinal_ulcer | 0.58170335 |
| 147 | MP0001544_abnormal_cardiovascular_syste | 0.57867384 |
| 148 | MP0005385_cardiovascular_system_phenoty | 0.57867384 |
| 149 | MP0002971_abnormal_brown_adipose | 0.57753301 |
| 150 | MP0008961_abnormal_basal_metabolism | 0.57315163 |
| 151 | MP0005253_abnormal_eye_physiology | 0.57004028 |
| 152 | MP0001485_abnormal_pinna_reflex | 0.55056353 |
| 153 | MP0008775_abnormal_heart_ventricle | 0.53498967 |
| 154 | MP0000750_abnormal_muscle_regeneration | 0.53278114 |
| 155 | MP0005670_abnormal_white_adipose | 0.50074283 |
| 156 | MP0005375_adipose_tissue_phenotype | 0.49963985 |
| 157 | MP0003115_abnormal_respiratory_system | 0.49178099 |
| 158 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.47680684 |
| 159 | MP0006036_abnormal_mitochondrial_physio | 0.47139164 |
| 160 | MP0001790_abnormal_immune_system | 0.47075667 |
| 161 | MP0005387_immune_system_phenotype | 0.47075667 |
| 162 | MP0003950_abnormal_plasma_membrane | 0.46581790 |
| 163 | MP0005275_abnormal_skin_tensile | 0.46343659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mesangial abnormality (HP:0001966) | 8.54121301 |
| 2 | Focal segmental glomerulosclerosis (HP:0000097) | 8.28448230 |
| 3 | Glomerulosclerosis (HP:0000096) | 6.72122309 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 6.49118226 |
| 5 | Nemaline bodies (HP:0003798) | 6.47588292 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.24841046 |
| 7 | Hypoalbuminemia (HP:0003073) | 6.21806923 |
| 8 | Abnormal albumin level (HP:0012116) | 6.21806923 |
| 9 | Exercise-induced myalgia (HP:0003738) | 6.12631946 |
| 10 | Aplasia involving bones of the extremities (HP:0009825) | 6.07636367 |
| 11 | Aplasia involving bones of the upper limbs (HP:0009823) | 6.07636367 |
| 12 | Aplasia of the phalanges of the hand (HP:0009802) | 6.07636367 |
| 13 | Hypomagnesemia (HP:0002917) | 5.49167888 |
| 14 | * Stage 5 chronic kidney disease (HP:0003774) | 5.24485662 |
| 15 | Metabolic alkalosis (HP:0200114) | 5.21114224 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 5.12910121 |
| 17 | Hypokalemic alkalosis (HP:0001949) | 5.08985700 |
| 18 | Increased circulating renin level (HP:0000848) | 5.02236820 |
| 19 | Abnormality of magnesium homeostasis (HP:0004921) | 4.95968664 |
| 20 | Abnormality of chloride homeostasis (HP:0011422) | 4.85147246 |
| 21 | Partial duplication of thumb phalanx (HP:0009944) | 4.80597812 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 4.78501623 |
| 23 | Partial duplication of the phalanx of hand (HP:0009999) | 4.60326755 |
| 24 | Alacrima (HP:0000522) | 4.43108805 |
| 25 | Abnormality of incisor morphology (HP:0011063) | 4.38747945 |
| 26 | Tubular atrophy (HP:0000092) | 4.26902680 |
| 27 | Conical tooth (HP:0000698) | 4.18469177 |
| 28 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.12437383 |
| 29 | Exercise-induced muscle cramps (HP:0003710) | 4.11929353 |
| 30 | Absent phalangeal crease (HP:0006109) | 4.10144351 |
| 31 | Abnormality of renin-angiotensin system (HP:0000847) | 4.02908630 |
| 32 | Recurrent corneal erosions (HP:0000495) | 4.00012001 |
| 33 | Metaphyseal dysplasia (HP:0100255) | 3.92979380 |
| 34 | Calf muscle hypertrophy (HP:0008981) | 3.83743592 |
| 35 | Decreased lacrimation (HP:0000633) | 3.73637415 |
| 36 | Polyuria (HP:0000103) | 3.71234195 |
| 37 | Hyperaldosteronism (HP:0000859) | 3.61902747 |
| 38 | Hypoproteinemia (HP:0003075) | 3.61262474 |
| 39 | * Nephrotic syndrome (HP:0000100) | 3.57425106 |
| 40 | Abnormal finger flexion creases (HP:0006143) | 3.50964659 |
| 41 | Abnormal urine output (HP:0012590) | 3.43654332 |
| 42 | Myoglobinuria (HP:0002913) | 3.35779419 |
| 43 | Distal arthrogryposis (HP:0005684) | 3.35656007 |
| 44 | Hyporeflexia of lower limbs (HP:0002600) | 3.32852006 |
| 45 | Polydipsia (HP:0001959) | 3.31234170 |
| 46 | Abnormal drinking behavior (HP:0030082) | 3.31234170 |
| 47 | Alkalosis (HP:0001948) | 3.31032560 |
| 48 | Tubulointerstitial fibrosis (HP:0005576) | 3.27478882 |
| 49 | Abnormality of renal excretion (HP:0011036) | 3.27372978 |
| 50 | Mixed hearing impairment (HP:0000410) | 3.26096135 |
| 51 | Corneal dystrophy (HP:0001131) | 3.23617000 |
| 52 | Neonatal respiratory distress (HP:0002643) | 3.23118062 |
| 53 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 3.19927024 |
| 54 | Myopathic facies (HP:0002058) | 3.19061133 |
| 55 | Renal salt wasting (HP:0000127) | 3.12328327 |
| 56 | Round ear (HP:0100830) | 3.12106050 |
| 57 | * Glomerulonephritis (HP:0000099) | 3.08163653 |
| 58 | Tetany (HP:0001281) | 3.05534569 |
| 59 | EMG: myopathic abnormalities (HP:0003458) | 3.04290893 |
| 60 | * Nephritis (HP:0000123) | 3.03567135 |
| 61 | Potter facies (HP:0002009) | 3.02356442 |
| 62 | Facial shape deformation (HP:0011334) | 3.02356442 |
| 63 | Abnormality of the salivary glands (HP:0010286) | 3.00386402 |
| 64 | * Proteinuria (HP:0000093) | 2.95151494 |
| 65 | Concave nail (HP:0001598) | 2.93268497 |
| 66 | Rhabdomyolysis (HP:0003201) | 2.92983454 |
| 67 | Difficulty running (HP:0009046) | 2.90464734 |
| 68 | Xerostomia (HP:0000217) | 2.86001210 |
| 69 | Muscle fiber splitting (HP:0003555) | 2.84194634 |
| 70 | Abnormality of the calf musculature (HP:0001430) | 2.82384899 |
| 71 | Anomalous pulmonary venous return (HP:0010772) | 2.78662432 |
| 72 | Aplasia of the musculature (HP:0100854) | 2.70952678 |
| 73 | Abnormality of the pulmonary veins (HP:0011718) | 2.70449934 |
| 74 | Abnormality of permanent molar morphology (HP:0011071) | 2.69766646 |
| 75 | Abnormality of the dental root (HP:0006486) | 2.69766646 |
| 76 | Taurodontia (HP:0000679) | 2.69766646 |
| 77 | Neck muscle weakness (HP:0000467) | 2.65564523 |
| 78 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.55180029 |
| 79 | Abnormality of the dental pulp (HP:0006479) | 2.54784375 |
| 80 | Abnormality of molar morphology (HP:0011070) | 2.54513060 |
| 81 | Abnormality of molar (HP:0011077) | 2.54513060 |
| 82 | Hypokalemia (HP:0002900) | 2.49347629 |
| 83 | Hypercalciuria (HP:0002150) | 2.44988265 |
| 84 | Muscle stiffness (HP:0003552) | 2.44407103 |
| 85 | Broad hallux (HP:0010055) | 2.43862800 |
| 86 | Abnormality of the lacrimal duct (HP:0011481) | 2.41456626 |
| 87 | Abnormality of potassium homeostasis (HP:0011042) | 2.39853959 |
| 88 | Tubulointerstitial abnormality (HP:0001969) | 2.39207254 |
| 89 | Hypoparathyroidism (HP:0000829) | 2.38820692 |
| 90 | Frequent falls (HP:0002359) | 2.37247880 |
| 91 | Duplication of thumb phalanx (HP:0009942) | 2.33806951 |
| 92 | Abnormality of the nasolacrimal system (HP:0000614) | 2.32741214 |
| 93 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.30995094 |
| 94 | Rapidly progressive (HP:0003678) | 2.30483461 |
| 95 | Asymmetric septal hypertrophy (HP:0001670) | 2.30255894 |
| 96 | Abnormal urine phosphate concentration (HP:0012599) | 2.29167689 |
| 97 | Increased connective tissue (HP:0009025) | 2.28935813 |
| 98 | * Hematuria (HP:0000790) | 2.28830115 |
| 99 | Delayed epiphyseal ossification (HP:0002663) | 2.28770277 |
| 100 | * Corneal erosion (HP:0200020) | 2.27035255 |
| 101 | Bundle branch block (HP:0011710) | 2.25301121 |
| 102 | Generalized muscle weakness (HP:0003324) | 2.23159564 |
| 103 | Hyperphosphaturia (HP:0003109) | 2.22011022 |
| 104 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.18009894 |
| 105 | Hypoplastic left heart (HP:0004383) | 2.17337237 |
| 106 | Keratoconus (HP:0000563) | 2.12897236 |
| 107 | Increased corneal curvature (HP:0100692) | 2.12897236 |
| 108 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.12490645 |
| 109 | Subaortic stenosis (HP:0001682) | 2.12490645 |
| 110 | Hypoplasia of the iris (HP:0007676) | 2.10200784 |
| 111 | Abnormality of the musculature of the hand (HP:0001421) | 2.09371140 |
| 112 | Thyroid-stimulating hormone excess (HP:0002925) | 2.08458127 |
| 113 | Ulnar deviation of the wrist (HP:0003049) | 2.08123063 |
| 114 | Ridged nail (HP:0001807) | 2.07571793 |
| 115 | Down-sloping shoulders (HP:0200021) | 2.04945054 |
| 116 | Hypoplasia of the ulna (HP:0003022) | 2.04044182 |
| 117 | Gastrointestinal stroma tumor (HP:0100723) | 2.03894907 |
| 118 | Abnormal hemoglobin (HP:0011902) | 2.03610928 |
| 119 | Ulnar claw (HP:0001178) | 2.01447858 |
| 120 | True hermaphroditism (HP:0010459) | 2.01238279 |
| 121 | Abnormality of the radial head (HP:0003995) | 2.00652293 |
| 122 | Seborrheic dermatitis (HP:0001051) | 2.00582675 |
| 123 | Hyponatremia (HP:0002902) | 2.00401490 |
| 124 | Synostosis involving the elbow (HP:0003938) | 1.99957874 |
| 125 | Humeroradial synostosis (HP:0003041) | 1.99957874 |
| 126 | Decreased circulating renin level (HP:0003351) | 1.98504349 |
| 127 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97609649 |
| 128 | EMG: neuropathic changes (HP:0003445) | 1.94979181 |
| 129 | Knee flexion contracture (HP:0006380) | 1.94963682 |
| 130 | Myotonia (HP:0002486) | 1.94293688 |
| 131 | Gonadal dysgenesis (HP:0000133) | 1.94292095 |
| 132 | Abnormality of the axillary hair (HP:0100134) | 1.92864015 |
| 133 | Abnormality of secondary sexual hair (HP:0009888) | 1.92864015 |
| 134 | Areflexia of lower limbs (HP:0002522) | 1.92336638 |
| 135 | Broad toe (HP:0001837) | 1.91783515 |
| 136 | Hyperkalemia (HP:0002153) | 1.91057071 |
| 137 | Abnormality of sodium homeostasis (HP:0010931) | 1.90360118 |
| 138 | Sudden death (HP:0001699) | 1.89073598 |
| 139 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.86592985 |
| 140 | Distal lower limb muscle weakness (HP:0009053) | 1.85500859 |
| 141 | Preaxial foot polydactyly (HP:0001841) | 1.85082204 |
| 142 | Abnormality of renal resorption (HP:0011038) | 1.84687485 |
| 143 | Hip contracture (HP:0003273) | 1.83403110 |
| 144 | Abnormal tarsal ossification (HP:0008369) | 1.82456729 |
| 145 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.81172695 |
| 146 | Malignant hyperthermia (HP:0002047) | 1.79321900 |
| 147 | * Nonprogressive disorder (HP:0003680) | 1.78755612 |
| 148 | Vascular calcification (HP:0004934) | 1.78539870 |
| 149 | Type I transferrin isoform profile (HP:0003642) | 1.76683758 |
| 150 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.76356313 |
| 151 | Parakeratosis (HP:0001036) | 1.72845350 |
| 152 | Limited hip movement (HP:0008800) | 1.72481769 |
| 153 | Hypothermia (HP:0002045) | 1.69990248 |
| 154 | Interstitial pulmonary disease (HP:0006530) | 1.69626322 |
| 155 | Adrenal overactivity (HP:0002717) | 1.69165657 |
| 156 | Pterygium (HP:0001059) | 1.68932465 |
| 157 | Optic disc pallor (HP:0000543) | 1.66222988 |
| 158 | Hypoplastic heart (HP:0001961) | 1.65661975 |
| 159 | Abnormality of Sharpey fibers (HP:0100685) | 1.63932051 |
| 160 | Attenuation of retinal blood vessels (HP:0007843) | 1.63092309 |
| 161 | Lymphangioma (HP:0100764) | 1.62259466 |
| 162 | Visceral angiomatosis (HP:0100761) | 1.60315150 |
| 163 | Reduced antithrombin III activity (HP:0001976) | 1.60015177 |
| 164 | Coronal craniosynostosis (HP:0004440) | 1.57116385 |
| 165 | Gout (HP:0001997) | 1.54812258 |
| 166 | Spontaneous hematomas (HP:0007420) | 1.54720150 |
| 167 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.53317654 |
| 168 | Peripheral hypomyelination (HP:0007182) | 1.52213898 |
| 169 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.52171946 |
| 170 | Absent/shortened dynein arms (HP:0200106) | 1.52171946 |
| 171 | Hypertensive crisis (HP:0100735) | 1.51407838 |
| 172 | Nasolacrimal duct obstruction (HP:0000579) | 1.50696837 |
| 173 | Cardiovascular calcification (HP:0011915) | 1.49456801 |
| 174 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.48886944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.16048855 |
| 2 | OXSR1 | 4.89100887 |
| 3 | WNK4 | 4.77803828 |
| 4 | CASK | 4.35823383 |
| 5 | STK39 | 4.24326717 |
| 6 | TIE1 | 3.71444746 |
| 7 | LATS1 | 3.39983030 |
| 8 | TNIK | 3.39153824 |
| 9 | TTN | 3.31929894 |
| 10 | EPHB2 | 3.29711876 |
| 11 | PHKG2 | 3.20239910 |
| 12 | PHKG1 | 3.20239910 |
| 13 | TRPM7 | 2.88670968 |
| 14 | WNK3 | 2.57044304 |
| 15 | MUSK | 2.51814172 |
| 16 | TGFBR2 | 2.50456934 |
| 17 | MOS | 2.37184919 |
| 18 | MKNK2 | 2.29080149 |
| 19 | MYLK | 2.23879695 |
| 20 | MST4 | 2.22303189 |
| 21 | PRKD2 | 2.11251775 |
| 22 | STK38L | 1.99722015 |
| 23 | PINK1 | 1.99688905 |
| 24 | MAPK15 | 1.87439718 |
| 25 | FES | 1.84647138 |
| 26 | MAP3K13 | 1.82001293 |
| 27 | KDR | 1.80367053 |
| 28 | TLK1 | 1.59667377 |
| 29 | RIPK1 | 1.57399917 |
| 30 | EPHA3 | 1.54598309 |
| 31 | CDK19 | 1.53766675 |
| 32 | CLK1 | 1.49405235 |
| 33 | GRK1 | 1.47732569 |
| 34 | PIK3CG | 1.46225605 |
| 35 | WNK1 | 1.44001808 |
| 36 | LATS2 | 1.43806811 |
| 37 | PDK2 | 1.33720809 |
| 38 | NLK | 1.33065666 |
| 39 | MAPK7 | 1.32960146 |
| 40 | FER | 1.31037602 |
| 41 | SGK2 | 1.28380559 |
| 42 | FRK | 1.22559638 |
| 43 | NME2 | 1.18624232 |
| 44 | IRAK2 | 1.13854648 |
| 45 | MELK | 1.13370292 |
| 46 | RIPK4 | 1.10632730 |
| 47 | EPHB1 | 1.09061287 |
| 48 | TRIB3 | 1.07497505 |
| 49 | IRAK3 | 1.04341494 |
| 50 | MKNK1 | 1.02017281 |
| 51 | STK16 | 1.01153341 |
| 52 | PDPK1 | 1.01062010 |
| 53 | IRAK1 | 0.99572091 |
| 54 | KIT | 0.98578495 |
| 55 | PAK4 | 0.97956172 |
| 56 | FGFR2 | 0.95068895 |
| 57 | STK38 | 0.94057736 |
| 58 | DAPK2 | 0.93577512 |
| 59 | SGK3 | 0.89141749 |
| 60 | PDK1 | 0.86424394 |
| 61 | TEC | 0.85344885 |
| 62 | BLK | 0.81850513 |
| 63 | AKT2 | 0.81383460 |
| 64 | IRAK4 | 0.81227860 |
| 65 | NEK9 | 0.80986930 |
| 66 | YES1 | 0.80715854 |
| 67 | TGFBR1 | 0.79281148 |
| 68 | STK10 | 0.79091583 |
| 69 | CSK | 0.77777431 |
| 70 | TBK1 | 0.77031933 |
| 71 | NEK6 | 0.77013012 |
| 72 | RET | 0.76849108 |
| 73 | ADRBK2 | 0.76770638 |
| 74 | FGFR4 | 0.74835962 |
| 75 | FGR | 0.74565992 |
| 76 | HIPK2 | 0.74372367 |
| 77 | MAP3K6 | 0.74312043 |
| 78 | GRK7 | 0.73880714 |
| 79 | PKN1 | 0.72789150 |
| 80 | JAK1 | 0.70083915 |
| 81 | MST1R | 0.69887040 |
| 82 | GSK3A | 0.68627501 |
| 83 | CSNK1G1 | 0.67810179 |
| 84 | MAP2K3 | 0.67291345 |
| 85 | NME1 | 0.67289272 |
| 86 | ROCK1 | 0.66316159 |
| 87 | MAP3K3 | 0.66291431 |
| 88 | FGFR3 | 0.66048326 |
| 89 | INSRR | 0.63088326 |
| 90 | RPS6KL1 | 0.60106640 |
| 91 | RPS6KC1 | 0.60106640 |
| 92 | SYK | 0.59428315 |
| 93 | ICK | 0.58898113 |
| 94 | CDC42BPA | 0.58350811 |
| 95 | PRKCE | 0.58002113 |
| 96 | MAPK13 | 0.56995103 |
| 97 | SRPK1 | 0.56956903 |
| 98 | CDK3 | 0.55869426 |
| 99 | RPS6KA6 | 0.54800440 |
| 100 | EEF2K | 0.53419404 |
| 101 | STK11 | 0.53351149 |
| 102 | SIK1 | 0.52673445 |
| 103 | CAMK1 | 0.52280852 |
| 104 | PRKAA1 | 0.52187294 |
| 105 | MAPK11 | 0.52009800 |
| 106 | EIF2AK2 | 0.51865384 |
| 107 | PAK2 | 0.51344897 |
| 108 | TAOK3 | 0.50381456 |
| 109 | EIF2AK3 | 0.49029404 |
| 110 | MAPKAPK3 | 0.48448952 |
| 111 | SGK494 | 0.47708505 |
| 112 | SGK223 | 0.47708505 |
| 113 | MAPK12 | 0.47384701 |
| 114 | UHMK1 | 0.46805766 |
| 115 | ADRBK1 | 0.46664322 |
| 116 | STK3 | 0.46329003 |
| 117 | MAP2K1 | 0.46111945 |
| 118 | PRKD1 | 0.44158823 |
| 119 | MAP3K14 | 0.42568642 |
| 120 | MTOR | 0.42293702 |
| 121 | ABL2 | 0.41127906 |
| 122 | MAP2K6 | 0.41077280 |
| 123 | MAP3K7 | 0.40660703 |
| 124 | NTRK1 | 0.39915444 |
| 125 | MAPKAPK5 | 0.39797691 |
| 126 | ARAF | 0.39513383 |
| 127 | CSNK1A1L | 0.39435836 |
| 128 | GRK5 | 0.39105868 |
| 129 | TYK2 | 0.38911625 |
| 130 | MAP3K1 | 0.38896057 |
| 131 | MAPK3 | 0.37367585 |
| 132 | MAPK4 | 0.36770383 |
| 133 | MAP2K7 | 0.35913228 |
| 134 | PRPF4B | 0.35528081 |
| 135 | MARK2 | 0.34460761 |
| 136 | CAMKK2 | 0.33911252 |
| 137 | ROCK2 | 0.33789111 |
| 138 | ABL1 | 0.32957906 |
| 139 | JAK2 | 0.32452414 |
| 140 | CDK12 | 0.32082417 |
| 141 | CAMK2A | 0.32037051 |
| 142 | MAP3K12 | 0.31814686 |
| 143 | BMPR1B | 0.31508739 |
| 144 | SGK1 | 0.30933067 |
| 145 | MET | 0.30519237 |
| 146 | PRKG2 | 0.29642737 |
| 147 | * PRKACA | 0.28718876 |
| 148 | PBK | 0.28251987 |
| 149 | FYN | 0.26475764 |
| 150 | VRK1 | 0.26448797 |
| 151 | PRKAA2 | 0.24318055 |
| 152 | CSNK1G3 | 0.24226889 |
| 153 | IKBKE | 0.22765819 |
| 154 | RPS6KA5 | 0.22691149 |
| 155 | BMPR2 | 0.22371933 |
| 156 | TXK | 0.21112226 |
| 157 | MAP2K2 | 0.20710329 |
| 158 | PRKCQ | 0.20340961 |
| 159 | CAMK2G | 0.18673734 |
| 160 | AKT3 | 0.18367322 |
| 161 | IGF1R | 0.16747124 |
| 162 | PRKG1 | 0.16448729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.60428434 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 3.96487219 |
| 3 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 3.19318492 |
| 4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.00227925 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.94955667 |
| 6 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 2.79257844 |
| 7 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.74326413 |
| 8 | Axon guidance_Homo sapiens_hsa04360 | 2.51387878 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.39252307 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.25067988 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.20386727 |
| 12 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 2.15360794 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 1.95650239 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.94924176 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.94808950 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.86991810 |
| 17 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 1.83910564 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.67199796 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61746847 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.57972751 |
| 21 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.50197824 |
| 22 | Lysine degradation_Homo sapiens_hsa00310 | 1.48952817 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.44162948 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43636366 |
| 25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.41728062 |
| 26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.39241416 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37991922 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.32496082 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32200038 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.31972275 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.31939360 |
| 32 | * Focal adhesion_Homo sapiens_hsa04510 | 1.28961735 |
| 33 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.28694189 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.27948722 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27646684 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.24985036 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.24572925 |
| 38 | Ribosome_Homo sapiens_hsa03010 | 1.23994549 |
| 39 | Melanoma_Homo sapiens_hsa05218 | 1.23750572 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19791922 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.15098223 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.11846689 |
| 43 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09974101 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08613833 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07717199 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 1.07641096 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.04633712 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02065626 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01450481 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 1.01140961 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99541647 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98801697 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97402550 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.97007135 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96704913 |
| 56 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.95700638 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94494656 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94381487 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.94322899 |
| 60 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.94122869 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.93631012 |
| 62 | Taste transduction_Homo sapiens_hsa04742 | 0.93432062 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92578463 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92335354 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92038329 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91662494 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.90159752 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89996734 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89209775 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.88577989 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88370309 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.88089902 |
| 73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87176095 |
| 74 | * Amoebiasis_Homo sapiens_hsa05146 | 0.86258871 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.85802517 |
| 76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.85761142 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82996424 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 0.82987739 |
| 79 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.82615917 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.82167180 |
| 81 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.79385676 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79127100 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78797369 |
| 84 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78759562 |
| 85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.78315274 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76442823 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76259137 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76003258 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75832056 |
| 90 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75794144 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74385198 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.72232028 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.71665289 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71620991 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71339487 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70629699 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70575916 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70130746 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.69633697 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69434254 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69290240 |
| 102 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66322590 |
| 103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66214195 |
| 104 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65743218 |
| 105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65508363 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61789023 |
| 107 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61625782 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.61076121 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60116861 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59814113 |
| 111 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59306299 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.59206060 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.58466861 |
| 114 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58309699 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.57771015 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57484343 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56166961 |
| 118 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.55477276 |
| 119 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55187993 |
| 120 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55096041 |
| 121 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54605231 |
| 122 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.54488497 |
| 123 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53158792 |
| 124 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53123285 |
| 125 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52714910 |
| 126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52676053 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.52401008 |
| 128 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52147402 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50600970 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.50346907 |
| 131 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.48316793 |
| 132 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48258903 |
| 133 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48206058 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47652046 |
| 135 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47584869 |
| 136 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46594707 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46131412 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44481230 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44044033 |
| 140 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43373837 |
| 141 | Insulin secretion_Homo sapiens_hsa04911 | 0.43093173 |
| 142 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42700030 |
| 143 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42327286 |
| 144 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42171244 |
| 145 | GABAergic synapse_Homo sapiens_hsa04727 | 0.41911092 |
| 146 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41747317 |
| 147 | Melanogenesis_Homo sapiens_hsa04916 | 0.41571625 |
| 148 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41208327 |
| 149 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39638330 |
| 150 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39108981 |
| 151 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38540452 |
| 152 | Phagosome_Homo sapiens_hsa04145 | 0.37231875 |
| 153 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37020154 |
| 154 | Lysosome_Homo sapiens_hsa04142 | 0.36982805 |
| 155 | Gap junction_Homo sapiens_hsa04540 | 0.36188234 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35578101 |
| 157 | Circadian entrainment_Homo sapiens_hsa04713 | 0.34261590 |
| 158 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32975091 |
| 159 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.32236265 |

